AstraZeneca's Fasenra spares asthma patients from steroid use in large trial

[cafead]

via In a single-arm phase 3b trial, Fasenra helped 62% of nearly 600 patients with severe asthma to go on about their lives without oral corticosteroids, AstraZeneca said Thursday. More patients, or 81%, had their daily steroid dose reduced to 5mg or below, including those who stopped use completely.

article source